Major β blocker mortality trials in chronic heart failure: a critical review
Open Access
- 1 December 1999
- Vol. 82 (suppl 4) , IV14-IV22
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart FailureNew England Journal of Medicine, 1998
- Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparisonEuropean Heart Journal, 1998
- Safety and efficacy of carvedilol in severe heart failureJournal of Cardiac Failure, 1997
- Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical TrialsJACC, 1997
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991